Context dependent roles for RB-E2F transcriptional regulation in tumor suppression

Michael J Thwaites1,2, Matthew J Cecchini3, Daniel T Passos1,2

  • 1London Regional Cancer Program, Lawson Health Research Institute, London, Ontario, Canada.

Plos One
|February 1, 2019
PubMed

Insights

Defects in RB-E2F transcriptional control are not always linked to cancer. However, when combined with specific genetic vulnerabilities, such as Trp53 deficiency, these RB-E2F defects can promote cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • RB-E2F transcriptional control is crucial for G1 to S-phase cell cycle progression.
  • This control is dispensable for cell cycle exit during growth arrest.
  • Mice lacking RB-E2F control show normal lifespan and no cancer predisposition.

Purpose of the Study:

  • To investigate the vulnerabilities associated with RB-E2F transcriptional control defects.
  • To examine the oncogenic potential of RB-E2F defects in combination with other genetic mutations.

Main Methods:

  • Generation of Rb1R461E,K542E mutant mice (Rb1G).
  • Genetic crosses of Rb1G/G mice with Trp53, Cdkn1a deficient, and KrasG12D mutant mice.
  • Assessment of cancer susceptibility and oncogenic effects.

Main Results:

  • The Rb1G mutation exacerbated cancer susceptibility when combined with Trp53 deficiency.
  • Rb1G mutation showed no effect in combination with Cdkn1a deficiency.
  • Rb1G mutation had no effect in combination with KrasG12D mutation.

Conclusions:

  • Compromised RB-E2F transcriptional control is not universally oncogenic.
  • Specific genetic contexts, like Trp53 deficiency, reveal potent oncogenic effects of RB-E2F defects.
  • This highlights context-dependent vulnerabilities in cancer development.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.3K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
686